These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7946273)

  • 1. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
    Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
    APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
    Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
    Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of fibronectin isoforms in human renal disease.
    Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
    J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.
    Midulla M; Verma R; Pignatelli M; Ritter MA; Courtenay-Luck NS; George AJ
    Cancer Res; 2000 Jan; 60(1):164-9. PubMed ID: 10646869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.
    Pujuguet P; Hammann A; Moutet M; Samuel JL; Martin F; Martin M
    Am J Pathol; 1996 Feb; 148(2):579-92. PubMed ID: 8579120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
    Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
    Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
    J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
    Dabelsteen E; Graem N; Hakomori S; Young WW
    Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.
    Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K
    Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
    Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
    Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
    Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
    Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
    Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
    Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
    Halliday NL; Rayan GM; Zardi L; Tomasek JJ
    J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.
    Borsi L; Balza E; Allemanni G; Zardi L
    Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of alpha(v)beta6 integrin in oral leukoplakia.
    Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
    Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis.
    Vogel W; Berndt A; Müller A; Dahse R; Haas KM; Borsi L; Zardi L; Kosmehl H
    Int J Mol Med; 2003 Dec; 12(6):831-7. PubMed ID: 14612953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate changes in squamous cell carcinomas.
    Dabelsteen E; Clausen H; Mandel U
    APMIS Suppl; 1992; 27():130-8. PubMed ID: 1520522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Several non-traumatic examination methods for oral leukoplakia lichen planus and carcinoma].
    Pang JF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1990 Sep; 25(5):282-4, 318. PubMed ID: 2128251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.